FDA Inspection 606887 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3003369924

The FDA completed an inspection of Biomat USA, Inc. on August 18, 2009 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chicago, IL (United States)